WCN'26: Industry Symposium 35: GLP1-RAs in Kidney Disease: Mechanisms, Applications in Clinical Practice and the Future

Recorded On: 03/30/2026

  • Register
    • Non-member - Free!
    • Member - Free!
    • Subscriber - Free!
    • Free trial - Free!

    Continue

WCN'26: Industry Symposium 35: GLP1-RAs in Kidney Disease: Mechanisms, Applications in Clinical Practice and the Future

The scientific content of this symposium has been independently developed by ISN. Supported by Novo Nordisk

Key:

Complete
Failed
Available
Locked
Mechanistic Effects of Semaglutide on Kidney Disease in Type 2 Diabetes: The REMODEL trial
Open to view video.
Open to view video.
You must register to access.
Multiparametric Imaging and Tissue Transcriptomics to Unravel Mechanisms of Kidney Protection
Open to view video.
Open to view video.
You must register to access.
GLP1s in Combination With Other Therapies and Applications in Clinical Practice
Open to view video.
Open to view video.
You must register to access.
The Future of GLP1s and Other Incretin-based Therapies for Kidney Disease
Open to view video.
Open to view video.
You must register to access.